CRT 2025

RETROGRADE APPROACH

Moderator(s)

• 

  Lorenzo Azzalini, MD, PhD, MSc

  Interventional Cardiologist
  University of Washington
  Seattle, Washington, United States

  Disclosure(s): Abbott Vascular: Consulting Fees (e.g., advisory boards) (Ongoing); Abiomed: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); GE Healthcare: Consulting Fees (e.g., advisory boards) (Terminated, December 11, 2024); HeartFlow: Consulting Fees (e.g., advisory boards) (Ongoing); Reflow Medical: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Shockwave Medical, Inc: Consulting Fees (e.g., advisory boards) (Ongoing); Teleflex: Consulting Fees (e.g., advisory boards) (Ongoing)
• 

  Kevin Croce, MD, PhD

  Director of CTO and Complex PCI Programs
  Brigham and Women's Hospital
  Harvard Medical School
  Boston, Massachusetts, United States

  Disclosure information not submitted.
• 

  Carlo Di Mario, MD

  Professor
  University of Florence
  Florence, Toscana, Italy

  Disclosure(s): BSC, Amgen, BCRI, PERC, NAMSA, BMS, Janssen, Regeneron: Grant/Research Support (Terminated, September 7, 2023)
• MP

  Megha Prasad, MD

  Assistant professor
  Columbia university

  Disclosure information not submitted.